Page last updated: 2024-08-23

raloxifene hydrochloride and verapamil

raloxifene hydrochloride has been researched along with verapamil in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baubichon-Cortay, H; Boumendjel, A; Di Pietro, A; Perrotton, T; Trompier, D	1
Chang, JH; Kochansky, CJ; Shou, M	1

Reviews

1 review(s) available for raloxifene hydrochloride and verapamil

Article	Year
Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents. Medicinal research reviews, 2005, Volume: 25, Issue:4 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavonoids; Humans; Raloxifene Hydrochloride; Structure-Activity Relationship; Verapamil	2005

Other Studies

1 other study(ies) available for raloxifene hydrochloride and verapamil

Article	Year
The role of P-glycoprotein in the bioactivation of raloxifene. Drug metabolism and disposition: the biological fate of chemicals, 2006, Volume: 34, Issue:12 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Cells, Cultured; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Fomepizole; Glutathione; Hepatocytes; Humans; Ketoconazole; Microsomes, Liver; Naphthalenes; Pyrazoles; Raloxifene Hydrochloride; Verapamil	2006

Article

Year

The role of P-glycoprotein in the bioactivation of raloxifene.

Drug metabolism and disposition: the biological fate of chemicals, 2006, Volume: 34, Issue:12

Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Cells, Cultured; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Fomepizole; Glutathione; Hepatocytes; Humans; Ketoconazole; Microsomes, Liver; Naphthalenes; Pyrazoles; Raloxifene Hydrochloride; Verapamil

2006